Yes you are correct
It was also around $2.50 when Viraleze was introduced into the UK around February March 2021
I am now talking about the future of Starpharma going forward into 2022/2023 calendar year
We have been signed with Merck for close to 18 months..........surely they are just about ready to begin first in human clinical trials with ADC's
Our Dep read outs will be made public very soon
Another couple of candidates going into in house clinics
Another new partnership in radiotherapeutics is just around the corner
Viraleze will be approved in Australia and continue to be widely distributed as an antiviral
FDA NDA approval (wishful thinking)
The list goes on
Am I deluded
I hope not
Yes you are correct It was also around $2.50 when Viraleze was...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
-0.003(3.06%) |
Mkt cap ! $39.17M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.5¢ | $12.55K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 586785 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 56840 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |